Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 1.04% | 84.48 | 0.9% | $1037.96m | |
| KITE | Kite Pharma, Inc. | 0.18% | 179.63 | 16.1% | $788.56m | |
| CELG | Celgene Corporation | -0.48% | 144.24 | 1.1% | $523.61m | |
| AMGN | Amgen Inc. | -0.08% | 186.14 | 1.1% | $498.96m | |
| BIIB | Biogen Inc. | -0.29% | 316.58 | 1.2% | $434.74m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.35% | 436.63 | 2.7% | $369.01m | |
| ALNY | Alnylam Pharmaceuticals, Inc | -4.14% | 112.19 | 10.7% | $259.10m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -2.66% | 140.13 | 1.9% | $232.10m | |
| JUNO | Juno Therapeutics, Inc. | -1.37% | 41.75 | 14.6% | $228.36m | |
| INCY | Incyte Corporation | -0.64% | 108.99 | 2.6% | $223.61m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.24% | 149.45 | 1.9% | $216.83m | |
| ILMN | Illumina, Inc. | -1.18% | 199.00 | 3.5% | $163.10m | |
| BLUE | Bluebird Bio, Inc. | -2.30% | 127.50 | 19.3% | $145.94m | |
| BMRN | BioMarin Pharmaceutical Inc. | -1.24% | 93.22 | 4.4% | $140.71m | |
| CLVS | Clovis Oncology, Inc. | -3.07% | 73.63 | 18.0% | $133.35m |
Company Profile
Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel medicines to address hematology indications. It offers next generation hemostasis programs and anti-complement assets. The company was founded on August 5, 2002 and is headquartered in South San Francisco, CA.